These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9810313)

  • 1. [Pharmacokinetics of anti-infective agents in continuous hemofiltration].
    Jaumain H; Clapson D; Allavéna MC; Allaouchiche B
    Presse Med; 1998 Oct; 27(30):1536-44. PubMed ID: 9810313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New experiences with the therapy of acute kidney injury.
    Kes P; Basić Jukić N
    Prilozi; 2008 Dec; 29(2):119-53. PubMed ID: 19259043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies.
    Hernandez SH; Howland M; Schiano TD; Hoffman RS
    Clin Toxicol (Phila); 2015; 53(10):941-9. PubMed ID: 26484583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Zahalkova J; Duricova J; Kacirova I; Brozmanova H; Urbanek K; Grundmann M; Martinek A
    J Chemother; 2012 Apr; 24(2):107-12. PubMed ID: 22546767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapies for critically ill pediatric patients.
    Sakarcan A; Karaböcüoğlu M
    Turk J Pediatr; 1995; 37(1):7-13. PubMed ID: 7732612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal replacement therapy in the intensive care unit].
    Kooman JP; van Bommel EF; van der Sande FM; Leunissen KM
    Ned Tijdschr Geneeskd; 2001 Dec; 145(48):2317-21. PubMed ID: 11766300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievements and new directions in continuous renal replacement therapies.
    Ronco C; Barbacini S; Digito A; Zoccali G
    New Horiz; 1995 Nov; 3(4):708-16. PubMed ID: 8574601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous hemodiafiltration in children.
    Bishof NA; Welch TR; Strife CF; Ryckman FC
    Pediatrics; 1990 May; 85(5):819-23. PubMed ID: 2330246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial agents in renal failure.
    Livornese LL; Benz RL; Ingerman MJ; Santoro J
    Infect Dis Clin North Am; 1995 Sep; 9(3):591-614. PubMed ID: 7490435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drugs in the intensive care unit--need for dosage adjustment in organ failure].
    Kroh UF; Lennartz H
    Klin Wochenschr; 1991; 69 Suppl 26():24-31. PubMed ID: 1813726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Removal of amino acids by continuous hemofiltration and hemodiafiltration].
    Gouyon JB; Françoise M; Desgres J; Petion AM; Sandre D
    Arch Pediatr; 1994 May; 1(5):501-4. PubMed ID: 7951837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous renal replacement therapy: evolution in technology and current nomenclature.
    Ronco C; Bellomo R
    Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
    Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL
    J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous hemofiltration as blood purification in sepsis.
    Bellomo R
    New Horiz; 1995 Nov; 3(4):732-7. PubMed ID: 8574604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.